TNB-404

N/A

Report date: 2025/01/26 15:10:43

Base Information

Drug NameTNB-404

Drug Alias Namecytokine (Teneobio)bispecific IL-2 receptor (IL-2R) beta/gamma chain agonists(Teneobio)TNB-404

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionInterleukin-2 receptor beta chain agonistsInterleukin-2 receptor alpha chain agonists

TargetsInterleukin-2 receptor beta chainInterleukin-2 receptor alpha chain

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesTeneobio Inc

China Registration ClassN/A

Develop Information

Active CompaniesAmgen Inc

Inactive CompaniesTeneobio Inc

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A